NCT00517036View on ClinicalTrials.gov

Omega-3 Fatty Acids for Treating Adults With Major Depression

PHASE3CompletedINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Depression
Interventions
DIETARY_SUPPLEMENT

EPA omega-3 fatty acid

1 gram per day of an EPA-enriched mixture for 8 weeks

DIETARY_SUPPLEMENT

DHA omega-3 fatty acid

1 gram per day of pure DHA for 8 weeks

DIETARY_SUPPLEMENT

Placebo comparator

1 gram per day of an inactive substance for 8 weeks

Trial Locations (1)

90048

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

collaborator

Massachusetts General Hospital

OTHER

lead

Cedars-Sinai Medical Center

OTHER

NCT00517036 - Omega-3 Fatty Acids for Treating Adults With Major Depression | Biotech Hunter | Biotech Hunter